BioSpace News Archive

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care and dermatological conditions today announced financial results for fiscal year 2020 and the fourth quarter ended March 31, 2020.

MilliporeSigma opened its M Lab™ Collaboration Center in Shanghai, the company’s largest of nine centers worldwide.

Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that TYME will hold its 2020 Annual Meeting of Stockholders in a virtual-only format, as a result of public health concerns relating to the coronavirus (COVID-19) and to protect the health and well-being of its share

Director General of the International Vaccine Institute (IVI) will speak to vaccine development and the role of contact tracing in combating coronavirus BOCA RATON, Fla.--( BUSINESS WIRE )-- Modernizing Medicine® , a leading healthcare technology company, is hosting a new installment in its thought leadership webinar series . The session, “World War C: Contact Tracing and the Hunt for a Vaccine,” will take place virtually on Tuesday, July 14 at 7 P

Apollo Med Innovations Introduces Novel Research-Based Testing Approach to Offer COVID-19 Antibody Testing to Nationwide Network of Over 1,000 Medical Clinics and Recently Launched Mobile Testing Platform ENGLEWOOD, CO / ACCESSWIRE / July 10, 2020 / Aytu BioScience, Inc. (NASDAQ:AYTU), a specialty pharmaceutical company (the “Company”) focused on commercializing novel products that address significant patient needs announced today that the Company has signed a distribution agreeme

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced call-in details for today’s investor conference call on Friday July 10 th 2020 at 4:15 PM Eastern time . The access information for the investor conference call is as follows: Domestic US/Canada – 1-(877) 830‑2586 Direct Toll / International - 1-(785) 424-1734 Program Title: NuGenerex Immuno‑Oncology ‑ Investor Conference Call Conference ID – 66974 Agenda

Company will offer choice of Covid-19 Kits to be sold Internationally, and then in the U.S. after receipt of FDA Authorization, as Saliva Based Kit is not anticipated to require changes to GenViro! Swift Test Strip or Meter except for Software Addition LOS ANGELES, CA / ACCESSWIRE / July 10, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) through its subsidiary Pharma Tech Solutions, Inc., today announced it plans to provide a new single-use saliva testing kit option to its professional a

A unique library of small-molecule fragments designed and developed by the National Cancer Institute’s RAS Initiative at the Frederick National Laboratory is now furthering the search for a COVID-19 treatment.

COVID-19 AND TREATMENT INNOVATION HEADLINE AAKP AND GW SCHOOL OF MEDICINE & HEALTH SCIENCES ANNUAL GLOBAL SUMMIT Registration Fees Dropped to Allow Frontline Medical Professionals and Patients Access

MedCrypt Inc. , a leading provider of proactive security solutions for the healthcare space, today announced it has joined the BlackBerry ® QNX ® Partner ecosystem, a worldwide network of technology companies who specialize in development tools, middleware, and embedded software products (e.g., database, HMI, and more) that are compat